Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Cresco Labs is still a buy, this analyst says

Summary by Cantech Letter
Cresco Labs (Cresco Labs Stock Quote, Chart, News, Analysts, Financials CSE:CL) is well-positioned to complete its debt refinancing and resume growth initiatives, Beacon Securities analyst Russell Stanley said Aug. 11. He maintained a “Buy” rating and C$1.75 share price target after the company reported second-quarter Adjusted EBITDA that beat the highest street estimate. Stanley said […] Source
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Cantech LetterCantech Letter

Cresco Labs is still a buy, this analyst says

Cresco Labs (Cresco Labs Stock Quote, Chart, News, Analysts, Financials CSE:CL) is well-positioned to complete its debt refinancing and resume growth initiatives, Beacon Securities analyst Russell Stanley said Aug. 11. He maintained a “Buy” rating and C$1.75 share price target after the company reported second-quarter Adjusted EBITDA that beat the highest street estimate. Stanley said […] Source

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Cantech Letter broke the news in on Wednesday, August 13, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Canada icon

Canada

News
For You
SearchBlindspotLocal